Devices and methods for treatment of heart failure by splanchnic nerve ablation
A method for treating a heart failure patient by ablating a nerve of the splanchnic sympathetic nervous system to increase venous capacitance and reduce pulmonary blood pressure. A method including: inserting a catheter into a vein adjacent the nerve, applying stimulation energy and observing hemodynamic effects, applying ablation energy and observing hemodynamic effects, applying simulation energy after the ablation and observing hemodynamic effects.
1. A method for treating a patient diagnosed with heart failure, comprising:
advancing a distal region of an endovascular catheter comprising one or more ablation elements into one of a T9, T10 or T11 intercostal vein;
activating an energy source disposed external to the patient and in operable communication with the one or more ablation elements;
delivering ablation energy with the one or more ablation elements to ablate a greater splanchnic nerve; and
removing the endovascular catheter from the patient.
2. The method of claim 1 , wherein advancing the distal region of the endovascular catheter into the T9, T10, or T11 intercostal vein comprises advancing at least one of the one or more ablation elements into the T9, T10, or T11 intercostal vein.
3. The method of claim 2 , wherein the endovascular catheter comprises one or more stimulation elements, and wherein advancing the distal region of the endovascular catheter into the T9, T10, or T11 intercostal vein comprises advancing at least one of the one or more stimulation elements into the T9, T10, or T11 intercostal vein.
4. The method of claim 1 , wherein advancing the distal region of the endovascular catheter into the T9, T10, or T11 intercostal vein comprises advancing a plurality of the one or more ablation elements into the T9, T10, or T11 intercostal vein.
5. The method of claim 1 , wherein the endovascular catheter comprises one or more stimulation elements, and wherein advancing the distal region of the endovascular catheter into the T9, T10, or T11 intercostal vein comprises advancing at least one of the one or more stimulation elements into the T9, T10, or T11 intercostal vein.
6. The method of claim 1 , wherein delivering the ablation energy occurs while the one or more ablation elements are disposed in an azygos vein space of the T9, T10 or T11 vertebrae.
7. The method of claim 6 , further comprising expanding a deployable structure that carries the one or more ablation elements in the azygos vein space of the T9, T10 or T11 vertebrae.
8. The method of claim 7 , wherein expanding the deployable structure comprises inflating an inflatable structure that carries the one or more ablation elements in the azygos vein space of the T9, T10 or T11 vertebrae.
9. The method of claim 7 , wherein expanding the deployable structure that carries the one or more ablation elements comprises moving the one or more ablation elements into apposition with a wall of the azygos vein.
10. The method of claim 7 , wherein the deployable structure further carries one or more stimulation elements, and wherein expanding the deployable structure comprises moving the one or more stimulation elements into apposition with an azygos vein wall, the method further comprising,
applying a stimulation level energy with at least one of the one or more stimulation elements; and
observing a physiologic response to assess proximity of the deployable structure to the greater splanchnic nerve.
11. The method of claim 6 , wherein the one or more ablation elements comprise a plurality of ablation elements, and wherein delivering the ablation energy comprises delivering energy with less than all of the plurality of ablation elements.
12. The method of claim 1 , wherein advancing the distal region of the endovascular catheter into one of a T9, T10 or T11 intercostal vein comprises femoral vein access or internal jugular vein access.
13. The method of claim 1 , wherein the heart failure comprises heart failure with preserved ejection fraction.
14. The method of claim 1 , further comprising, at a time subsequent to activating the energy source, assessing the patient's heart failure by assessing one or more of the patient's exercise capacity, blood pressure, or neurohormonal changes.
15. The method of claim 1 , further comprising confirming that the greater splanchnic nerve has been ablated.
16. The method of claim 1 , wherein ablating the greater splanchnic nerve treats the heart failure and causes an increase in exercise tolerance.
17. The method of claim 1 , wherein ablating the greater splanchnic nerve treats the heart failure and causes a decrease in blood pressure.